<DOC>
	<DOCNO>NCT01655108</DOCNO>
	<brief_summary>This study aim investigate effectiveness safety mesotherapy treatment female pattern alopecia . - Sixty female subject 18 65 year diagnose female pattern hair loss undergo mesotherapy session weekly ten week . - One group receive 0.5 % /2ml minoxidil application control group receive application placebo ( saline 0.9 % ) . - Biopsy scalp , trichogram trichoscopy ( Fotofinder ) perform 08 week treatment method objective evaluation response</brief_summary>
	<brief_title>Efficacy Safety Mesotherapy With Minoxidil 0.5 % /2ml Androgenetic Alopecia Female Patients</brief_title>
	<detailed_description>This trial aim analyze efficacy safety mesotherapy minoxidil 0,5 % versus placebo androgenetic alopecia female patient . The patient investigator analyze complementary exam blind . - Clinical criterion , photo , 4mm biopsia , trichogram trichoscopy perfomed patient randomize two arm : 1 . Group 1 ( Placebo ) : 30 patient intradermal injection scalp saline 0.9 % 2 . Group 2 ( Active Drug ) : 30 patient receive intradermal injection scalp minoxidil 0.5 % /2ml Eight week last session patient recruit repeat exam perform self-assessment effect hair growth effect hair loss .</detailed_description>
	<mesh_term>Alopecia</mesh_term>
	<mesh_term>Alopecia Areata</mesh_term>
	<mesh_term>Minoxidil</mesh_term>
	<criteria>Women 18 65 year old Androgenetic Alopecia ( female pattern hair loss ) patient alopecia areata cicatricial alopecia pregnancy breastfeed undergone specific treatment last 06 month use drug antiandrogenic property patient sign symptom hyperandrogynism</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Androgenetic Alopecia</keyword>
	<keyword>Mesotherapy</keyword>
	<keyword>Minoxidil</keyword>
	<keyword>Trichogram</keyword>
</DOC>